07 July 2022

After two years focusing mostly on one virus, many innovations in the space of AMR, microbiome or general surveillance were overlooked. This 50 minute panel will discuss the opportunities now arising in a more holistic approach to human – ‘bug’ interaction.

Facilitated by:
Richard Vickers, Senior Partner at tranScrip

Anne Neville, Director at Microbiotica 
Paul Branthwaite, Senior Partner at tranScrip
Mike Whelan, Project Leader at CEPI 
Martin Stocks, CEO at Iceni Glyoscience